Tonawanda, NY – March 7, 2024 – Pine Pharmaceuticals, one of the nation's largest and most trusted FDA-registered 503B outsourcing facilities, has announced the launch of moxifloxacin 0.5 mg and 0.75 mg, now available in ready-to-use vials. These latest additions...

   Pine Pharmaceuticals is pleased to announce the promotion of Gregory Reid to Director of Production. Over the past two years, Gregory played a key role in streamlining our operations, particularly during the successful integration of Athenex's 503B business...

  The start of 2025 has brought exciting growth and new opportunities for Pine Pharmaceuticals, and we are looking forward to what's ahead. As we move further into the year, we are eager to continue delivering the highest level of service to facilities...

Pine Pharmaceuticals is thrilled to announce the promotion of Adam Snyder to Director of Engineering and Maintenance. Over the past three years, Adam has played a pivotal role in driving innovation and operational excellence, contributing significantly to Pine's...

Tonawanda, NY, December 13, 2024—Pine Pharmaceuticals, one of the nation's largest and most trusted FDA-registered 503B outsourcing facilities, recently announced the launch of norepinephrine 32 mg, the newest addition to its collection of ready-to-administer premix...

In continuing Pine's 10th anniversary celebration, we asked Alfonse Muto and Alfonse J. Muto, Pharm.D. ten questions about their decade-long ownership journey and Pine's remarkable evolution. Here's what they had to share: 1. How does it feel to reflect on a decade of...

As one of the first facilities to register under section 503B, Pine Pharmaceuticals is celebrating ten years of uncompromising excellence! Founded in 2014 by father and son Alfonse Muto and Alfonse J. Muto, Pharm.D., Pine Pharmaceuticals established itself as an...

We are thrilled to announce that Pine Pharmaceuticals has been honored as Buffalo Business First's 2023 Business of the Year in the BioPharma sector! This remarkable achievement is a testament to the unwavering dedication and tireless efforts of our entire team,...

We're excited to announce that Pine Pharmaceuticals has been honored with the Excellence in Analytics award by MasterControl.  Spearheaded by our Innovation and Development Manager, James Ando, Pharm.D., MasterControl has been pivotal in transforming our reports into...

We're thrilled to announce that Buffalo Business First awarded Pine Pharmaceuticals a Brick by Brick award, recognizing our 50,000-square-foot expansion. These exclusive awards highlight the accomplishments of Western New York's real estate development industry. Thank...